Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: Characterization of pathways available to eosinophils for generating reactive nitrogen species

被引:228
作者
MacPherson, JC
Comhair, SAA
Erzurum, SC
Klein, DF
Lipscomb, MF
Kavuru, MS
Samoszuk, MK
Hazen, SL
机构
[1] Cleveland Clin Fdn, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA
[3] Cleveland Clin Fdn, Dept Canc Biol, Cleveland, OH 44195 USA
[4] Cleveland Clin Fdn, Dept Pulm & Crit Care Med, Cleveland, OH 44195 USA
[5] Cleveland Clin Fdn, Ctr Cardiovasc Diagnost, Cleveland, OH 44195 USA
[6] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA
[7] Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA
[8] Quest Diagnost, San Juan Capistrano, CA 92690 USA
关键词
D O I
10.4049/jimmunol.166.9.5763
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Eosinophil recruitment and enhanced production of NO are characteristic features of asthma. However, neither the ability of eosinophils to generate NO-derived oxidants nor their role in nitration of targets during asthma is established. Using gas chromatography-mass spectrometry we demonstrate a 10-fold increase in 3-nitrotyrosine (NO2Y) content, a global marker of protein modification by reactive nitrogen species, in proteins recovered from bronchoalveolar lavage of severe asthmatic patients (480 +/- 198 mu mol/mol tyrosine; n = 11) compared with nonasthmatic subjects (52.5 +/- 40.7 mu mol/mol tyrosine; n = 12). Parallel gas chromatography-mass spectrometry analyses of bronchoalveolar lavage proteins for 3-bromotyrosine (BrY) and 3-chlorotyrosine (ClY), selective markers of eosinophil peroxidase (EPO)- and myeloperoxidase-catalyzed oxidation, respectively, demonstrated a dramatic preferential formation of BrY in asthmatic (1093 +/- 457 mu mol BrY/mol tyrosine; 161 +/- 88 mu mol ClY/mol tyrosine; n = 11 each) compared with nonasthmatic subjects (13 +/- 14.5 mu mol BrY/mol tyrosine; 65 +/- 69 mu mol ClY/mol tyrosine; n = 12 each). Bronchial tissue from individuals who died of asthma demonstrated the most intense anti-NO2Y immunostaining in epitopes that colocalized with eosinophils. Although eosinophils from normal subjects failed to generate detectable levels of NO, NO2-, NO3-, or NO2Y, tyrosine nitration was promoted by eosinophils activated either in the presence of physiological levels of NO2- or an exogenous NO source. At low, but not high (e.g., >2 muM/min), rates of NO flux, EPO inhibitors and catalase markedly attenuated aromatic nitration. These results identify eosinophils as a major source of oxidants during asthma. They also demonstrate that eosinophils use distinct mechanisms for generating NO-derived oxidants and identify EPO as an enzymatic source of nitrating intermediates in eosinophils.
引用
收藏
页码:5763 / 5772
页数:10
相关论文
共 82 条
  • [1] Nitric oxide is a physiological substrate for mammalian peroxidases
    Abu-Soud, HM
    Hazen, SL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (48) : 37524 - 37532
  • [2] Nitric oxide modulates the catalytic activity of myeloperoxidase
    Abu-Soud, HM
    Hazen, SL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (08) : 5425 - 5430
  • [3] THE INJURIOUS EFFECT OF EOSINOPHIL PEROXIDASE, HYDROGEN-PEROXIDE, AND HALIDES ON PNEUMOCYTES INVITRO
    AGOSTI, JM
    ALTMAN, LC
    AYARS, GH
    LOEGERING, DA
    GLEICH, GJ
    KLEBANOFF, SJ
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1987, 79 (03) : 496 - 504
  • [4] DIAGNOSTIC-SIGNIFICANCE OF INCREASED BRONCHOALVEOLAR LAVAGE FLUID EOSINOPHILS
    ALLEN, JN
    DAVIS, WB
    PACHT, ER
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 142 (03): : 642 - 647
  • [5] Ashutosh K, 2000, Curr Opin Pulm Med, V6, P21, DOI 10.1097/00063198-200001000-00005
  • [6] OXYGEN-DEPENDENT MICROBIAL KILLING BY PHAGOCYTES .1.
    BABIOR, BM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (12) : 659 - 668
  • [7] BIOLOGICAL DEFENSE MECHANISMS - PRODUCTION BY LEUKOCYTES OF SUPEROXIDE A POTENTIAL BACTERICIDAL AGENT
    BABIOR, BM
    KIPNES, RS
    CURNUTTE, JT
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (03) : 741 - 744
  • [8] BAEK KJ, 1993, J BIOL CHEM, V268, P21120
  • [9] Nitric oxide and asthma
    Barnes, PJ
    [J]. RESEARCH IN IMMUNOLOGY, 1995, 146 (09): : 698 - 702
  • [10] Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424